Menopause Health Center
This article is from the WebMD News Archive
Acupuncture May Cool Night Hot Flashes
Sept. 22, 2006 -- Acupuncture may nix nighttime hot flashes caused by menopause, according to a new study.
Researchers found seven weeks of acupuncture treatment reduced the severity of nighttime hot flashes by 28% among menopausal women compared with a 6% decrease among women who had a sham acupuncture treatment.
Hot flashes are a common symptom of menopause and often occur at night, which can significantly disrupt sleep and affect a woman's quality of life.
Until recently, hormone replacement therapy (HRT) was the most popular treatment for hot flashes. But in the wake of studies that suggested HRT use could increase a woman's risk of heart diseaseheart disease or cancercancer, alternative therapies for hot flashes have received renewed interest.
Needles Cool Hot Flashes
Researchers compared the effects of acupuncture vs. a sham acupuncture treatment on the severity and frequency of nighttime hot flashes. Taking part in the study were 29 menopausal women experiencing at least seven moderate to severe hot flashes per day.
All of the women underwent nine treatments from trained acupuncturists in sessions over seven weeks. Twelve of the women received real acupuncture using points selected to target hot flashes and sleepiness. The rest of the women received a sham acupuncture treatment using nonpenetrating needles at random acupuncture channel points.
Throughout the study, the women reported the number and severity of their hot flashes.
The results showed that nighttime hot flash severity decreased significantly (28%) among the women who received acupuncture vs. a 6% drop among the women who got the sham treatment. However, they did not see a similar finding in the frequency of nighttime hot flashes between the two groups.
Researcher Mary Huang, MS, of Stanford University, and colleagues say the results suggest acupuncture deserves further study as an alternative treatment for menopausal hot flashes.
The findings are published in the September issue of Fertility and Sterility.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


